Heike Weidner

590 total citations
17 papers, 278 citations indexed

About

Heike Weidner is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Heike Weidner has authored 17 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Heike Weidner's work include Acute Myeloid Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (4 papers) and Bone health and treatments (3 papers). Heike Weidner is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (4 papers) and Bone health and treatments (3 papers). Heike Weidner collaborates with scholars based in Germany, United States and Austria. Heike Weidner's co-authors include Martina Rauner, Lorenz C. Hofbauer, Ulrike Baschant, Uwe Platzbecker, Ekaterina Balaian, Martin Bornhäuser, María G. Ledesma-Colunga, Antonella Roetto, Manja Wobus and Maja Vujić Spasić and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Heike Weidner

17 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heike Weidner Germany 11 122 103 88 43 42 17 278
Ekaterina Balaian Germany 9 100 0.8× 65 0.6× 80 0.9× 35 0.8× 14 0.3× 16 208
Zonghong Shao China 9 172 1.4× 173 1.7× 46 0.5× 73 1.7× 9 0.2× 34 342
Fernando Vieira Pericole Brazil 12 138 1.1× 123 1.2× 53 0.6× 64 1.5× 8 0.2× 34 286
Yanting Yu China 11 26 0.2× 135 1.3× 23 0.3× 24 0.6× 5 0.1× 21 309
Bei Zhang China 9 84 0.7× 105 1.0× 63 0.7× 20 0.5× 6 0.1× 32 250
M Hrubisko Slovakia 7 102 0.8× 61 0.6× 39 0.4× 157 3.7× 19 0.5× 25 276
Isabelle C. Becker United States 8 122 1.0× 43 0.4× 30 0.3× 48 1.1× 5 0.1× 24 221
Ashwin Sridharan United States 7 78 0.6× 132 1.3× 46 0.5× 96 2.2× 5 0.1× 17 308
Zarabeth Newton United Kingdom 3 95 0.8× 157 1.5× 19 0.2× 26 0.6× 3 0.1× 4 291
Mariateresa Pettinato Italy 8 119 1.0× 87 0.8× 101 1.1× 42 1.0× 1 0.0× 18 264

Countries citing papers authored by Heike Weidner

Since Specialization
Citations

This map shows the geographic impact of Heike Weidner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Weidner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Weidner more than expected).

Fields of papers citing papers by Heike Weidner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Weidner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Weidner. The network helps show where Heike Weidner may publish in the future.

Co-authorship network of co-authors of Heike Weidner

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Weidner. A scholar is included among the top collaborators of Heike Weidner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Weidner. Heike Weidner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ledesma-Colunga, María G., Ulrike Baschant, Heike Weidner, et al.. (2023). Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis. Redox Biology. 60. 102616–102616. 17 indexed citations
2.
Fischer, Luise, Sandra Hoffmann, Ronny Baber, et al.. (2023). Increased Bone Turnover and Decreased BCMA Levels in Patients with Response to Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma. Blood. 142(Supplement 1). 6643–6643. 1 indexed citations
3.
Weidner, Heike, Manja Wobus, Lorenz C. Hofbauer, Martina Rauner, & Uwe Platzbecker. (2022). Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice. Leukemia. 36(11). 2715–2718. 3 indexed citations
4.
Herbig, Maik, Angela Jacobi, Manja Wobus, et al.. (2022). Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes. Scientific Reports. 12(1). 870–870. 18 indexed citations
5.
Engleitner, Thomas, Baiba Vilne, Heike Weidner, et al.. (2022). Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300. Haematologica. 108(2). 490–501. 3 indexed citations
6.
Ledesma-Colunga, María G., Heike Weidner, Maja Vujić Spasić, et al.. (2021). Shaping the bone through iron and iron-related proteins. Seminars in Hematology. 58(3). 188–200. 27 indexed citations
7.
Wobus, Manja, Nandini Asokan, Uta Oelschlägel, et al.. (2021). Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells. Leukemia. 35(10). 2936–2947. 25 indexed citations
8.
Weidner, Heike, Ulrike Baschant, María G. Ledesma-Colunga, et al.. (2020). Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes. JCI Insight. 5(15). 21 indexed citations
9.
Weidner, Heike, Elena Tsourdi, Ravi Kumar, et al.. (2020). Disruption of BMP Signaling Prevents Hyperthyroidism-Induced Bone Loss in Male Mice. Journal of Bone and Mineral Research. 35(10). 2058–2069. 18 indexed citations
10.
Hannemann, Anke, Matthias Nauck, Henry Völzke, et al.. (2020). Interactions of Anemia, FGF-23, and Bone in Healthy Adults—Results From the Study of Health in Pomerania (SHIP). The Journal of Clinical Endocrinology & Metabolism. 106(1). e288–e299. 13 indexed citations
11.
Balaian, Ekaterina, Heike Weidner, Manja Wobus, et al.. (2019). Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes. Annals of Hematology. 98(9). 2063–2072. 10 indexed citations
12.
Thiele, Sylvia, Anke Hannemann, Maria Winzer, et al.. (2019). Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans. Endocrine Connections. 8(7). 923–934. 19 indexed citations
13.
Vinchi, Francesca, Richard Sparla, Sara Passos, et al.. (2018). Transfusion-Induced Impairment of Macrophage Responses Is Partially Restored By the Iron Chelator Deferasirox. Blood. 132(Supplement 1). 3625–3625. 2 indexed citations
14.
Balaian, Ekaterina, Manja Wobus, Heike Weidner, et al.. (2017). Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway. Haematologica. 103(1). 61–68. 16 indexed citations
15.
Weidner, Heike, Martina Rauner, Franziska Trautmann, et al.. (2017). Myelodysplastic syndromes and bone loss in mice and men. Leukemia. 31(4). 1003–1007. 25 indexed citations
16.
Baschant, Ulrike, Martina Rauner, Ekaterina Balaian, et al.. (2016). Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors. Haematologica. 101(12). 1499–1507. 58 indexed citations
17.
Weidner, Heike, Marius Bill, Madlen Jentzsch, et al.. (2014). High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia. Blood. 124(21). 1575–1575. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026